NASDAQ:ALBO

Albireo Pharma Earning Date

USA |NASDAQ |USD

ALBO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.38 $-1.90 $-1.96
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $3.48M $2.43M $2.13M

Albireo Pharma's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ALBO Earnings Date & History Chart

ALBO Earnings & Revenue Forecast

ALBO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-1.83 $-2.19 $-1.26
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-5.82 $-8.02 $-3.29
Dec 2022 8 $-6.31 $-8.59 $-4.69

ALBO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.81 $-1.81 $-1.79
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-6.64 $-6.64 $-7.79
Dec 2022 0 / 0 $-6.05 $-6.02 $-5.35

ALBO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $6.41M $3.58M $9.51M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $14.18M $10.30M $18.10M
Dec 2022 8 $54.33M $30.97M $65.41M

ALBO Earnings Date & Revenue History

ALBO Earnings History

|
Show More
Show More

ALBO Revenue History

|
Show More
Show More

Albireo Pharma Next Earnings Date & Report

ALBO Next Earnings Date & Report Preview: Sep 2021 (FQ)

ALBO's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Albireo Pharma's next quarterly earnings is $-0.38, with a low EPS estimation of $-1.96, and a high estimation of $2.57.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-1.06, the last 2 month trend is $-1.20, and the 3 month trend is $-1.35.

Based on 7 analysts, the average revenue estimation is $3.48M, with a low revenue estimation of $2.26M, and a high estimation of $4.20M.

Albireo Pharma Previous Earnings Dates & Reports

ALBO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Albireo Pharma's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ALBO's earnings per share (EPS) was $-1.90, beating the consensus analysts forecast of $-1.97 by 3.43%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -17.03%, and lower than the same period a year before (Jun 2020) by 37.68%.

Revenues were $2.43M, better than the forecast of $2.43M by 0.00%, up by 23.50% from the previous quarter , and up by 26.99% from the same period last year.

The company reported a net income of $-36.42M.

Free cash flow for the quarter was $-31.75M , compared to $-34.72M last quarter and $-23.14M a year before.

ALBO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Albireo Pharma's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

ALBO's earnings per share (EPS) was $-6.87, beating the consensus analysts forecast of $-7.39 by -7.04% , and lower than the previous year's EPS (Dec 2019) by 36.31%.

Revenues were $8.31M, better than the forecast of $8.01M by 3.72%, and down by -13.78% from previous year's revenue.

The company reported a net income of $-107.63M.

Albireo Pharma reported a free cash flow of $-101.11M for its fiscal year, compared to $-53.46M a year ago.

The company ended the fiscal year with $12.70M in total debt. lala